Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'mda'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Roberts AS, Alexander F Report on Clinical Evaluation of SKF #5 (Amphedoxamine) [MDA] [Memo, 1957 Aug 21] 1957
Naranjo C, Shulgin AT, Sa... Evaluation of 3,4-methylenedioxyamphetamine MDA as an adjunct to psych... Med Pharmacol Exp In... 1967
Richards RN Experience with MDA Can Med Assoc J 1972
Turek IS, Soskin RA, Kurl... Methylenedioxyamphetamine (MDA) Subjective Effects Journal of Psychedel... 1974
Nichols DE, Ilhan M, Long... Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... Arch Int de Pharmaco... 1975
Yensen R The Use of 3, 4 Methylenedioxyamphetamine (MDA) as an Adjunct to Brief... Dissertation UC Irvi... 1975
Lopatka JE, Brewerton CN,... The protective effects of methysergide, 6-hydroxydopamine and other ag... Res Commun Chem Path... 1976
Yensen R, Di Leo FB, Rhea... MDA-assisted psychotherapy with neurotic outpatients: a pilot study J Nerv Ment Dis 1976
Marquardt GM, DiStefano V... Pharmacological effects of (+/-)-, (S)-, and (R)-MDA Psychopharmacology o... 1976
Shulgin, A. Profiles of Psychedelic Drugs: MMDA Journal of Psychoact... 1976
Shannon HE MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-... Psychopharmacology 1980
Davis WM, Borne RF Pharmacologic investigation of compounds related to 3,4-methylenedioxy... Subst Alcohol Action... 1984
Glennon RA, Young R MDA: An Agent That Produces Stimulus Effects Similar to Those of 3,4-D... European J Pharmacol 1984
Brady JF, Di Stefano EW, ... Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphet... Life Sci 1986
Climko RP, Roehrich H, Sw... Ecstacy: a review of MDMA and MDA Int J Psychiatry Med 1986
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Davis WM, Catravas JD, Wa... Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) ... Gen Pharmacol 1986
Davis WM, Hatoum HT, Wate... Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... Alcohol Drug Res 1987
Rosecrans JA, Glennon RA The effect of MDA and MDMA ('Ecstasy') isomers in combination with pir... Pharmacol Biochem Be... 1987
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Glennon RA, Yousif M, Pat... Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MD... Pharmacol Biochem Be... 1988
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988
Ramos JM Jr, Fitzgerald R... MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/met... Clin Chem 1988
De Souza EB, Battaglia G Effects of MDMA and MDA on brain serotonin neurons: evidence from neur... NIDA Res Monogr 1989
Fitzgerald RL, Blanke RV,... Stereochemistry of the metabolism of MDMA to MDA Life Sci 1989
Glennon RA, Misenheimer B... Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... Pharmacol Biochem Be... 1989
Nader MA, Hoffmann SM, Ba... Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... Psychopharmacology (... 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Glennon RA, Misenheimer B... Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... Pharmacol Biochem Be... 1989
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
McCann UD, Ricaurte GA Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not m... Brain Res 1991
Olney JW, Labruyere J, Wa... NMDA antagonist neurotoxicity: mechanism and prevention Science 1991
Broadbent JJ, Appel JB J,... Discriminative stimulus effects of the optical isomers of 3,4-methylen... Behavioural Pharmaco... 1992
Michel RE, Rege AB, Georg... High-pressure liquid chromatography/electrochemical detection method f... J Neurosci Methods 1993
Poklis A, Fitzgerald RL, ... EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detectio... Forensic Sci Int 1993
Cadet JL, Ladenheim B, Ba... CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to... Brain Res 1994
Nash JF, Roth BL, Brodkin... Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl in... Neurosci Lett 1994
Colado MI, Williams JL, G... The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... Br J Pharmacol 1995
Hegadoren KM, Baker GB, C... Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (... J Pharmacol Toxicol ... 1995
Bronson ME, Jiang W, DeRu... A behavioral comparison of Nexus, cathinone, BDB, and MDA Pharmacol Biochem Be... 1995
Moore KA, Mozayani A, Fie... Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methy... Forensic Sci Int 1996
Bronson ME, Wages TD, Bed... Morphine, MDMA, MDA, and nexus produce a conditioned place preference ... Exp Clin Psychopharm... 1996
Tucker G Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedi... Hum Exp Toxicol 1996
Kunsman GW, Levine B, Kuh... MDA-MDMA concentrations in urine specimens J Anal Toxicol 1996
Baker LE, Taylor MM Assessment of the MDA and MDMA optical isomers in a stimulant-hallucin... Pharmacol Biochem Be... 1997
Dal Cason TA, Meyers JA, ... Erratum to ‘Proton and Carbon-13 NMR assignments of 3,4-methylenedioxy... Forensic Sci Int 1997
Colado MI, Granados R, O'... Role of hyperthermia in the protective action of clomethiazole against... Br J Pharmacol 1998
Farber NB, Hanslick J, Ki... Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... Neuropsychopharmacol... 1998
Parker MA, Marona-Lewicka... Synthesis and pharmacological evaluation of ring-methylated derivative... J Med Chem 1998
Hensley D, Cody JT Simultaneous determination of amphetamine, methamphetamine, methylened... J Anal Toxicol 1999
Arvanov VL, Liang X, Russ... LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... Eur J Neurosci 1999
Jurado C, Gimenez MP, et ... Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine... J Anal Toxicol 2000
Russell BR, Laverty R Correlation between 5-HT content and uptake site density following (S)... Ann N Y Acad Sci 2000
Pentney AR An exploration of the history and controversies surrounding MDMA and M... J Psychoactive Drugs 2001
Clauwaert KM, Van Bocxlae... Stability study of the designer drugs 'MDA, MDMA and MDEA' in water, s... Forensic Sci Int 2001
Krupitsky EM, Burakov AM,... Attenuation of ketamine effects by nimodipine pretreatment in recoveri... Neuropsychopharmacol... 2001
Gandolfi O, Gaggi R, Volt... The activation of serotonin receptors prevents glutamate-induced neuro... Pharmacol Res 2002
Nordgren HK, Beck O Direct screening of urine for MDMA and MDA by liquid chromatography-ta... J Anal Toxicol 2003
De Letter EA, Espeel MF, ... Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... Int J Legal Med 2003
Stout PR, Klette KL, Wieg... Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscre... J Anal Toxicol 2003
Huang Z, Zhang S Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine sa... J Chromatogr B Analy... 2003
Schifano F, Oyefeso A, Co... Death rates from ecstasy (MDMA, MDA) and polydrug use in England and W... Hum Psychopharmacol 2003
Easton N, Fry J, O'Shea E... Synthesis, in vitro formation, and behavioural effects of glutathione ... Brain Res 2003
Moyano S, Frechilla D, De... NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... Psychopharmacology (... 2004
Schifano F A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities Psychopharmacology (... 2004
da Costa JL, da Matta Cha... Determination of MDMA, MDEA and MDA in urine by high performance liqui... J Chromatogr B Analy... 2004
Concheiro M, de Castro A,... Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high per... Forensic Sci Int 2005
Elliott SP MDMA and MDA concentrations in antemortem and postmortem specimens in ... J Anal Toxicol 2005
Lambe EK, Aghajanian GK Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... Neuropsychopharmacol... 2005
Bexis S, Docherty JR Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor... Br J Pharmacol 2006
Drees JC, Stone JA, Wu AH Morbidity involving the hallucinogenic designer amines MDA and 2C-I J Forensic Sci 2009
Baggott MJ, Siegrist JD, ... Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4... Plos One 2010
Reissig CJ, Carter LP, Jo... High doses of dextromethorphan, an NMDA antagonist, produce effects si... Psychopharmacology (... 2012
Dal Cason TA, Corbett CA,... An unusual clandestine laboratory synthesis of 3,4-methylenedioxyamphe... Forensic Sci Int 2012
Sanacora G, Smith MA, Pat... Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... Mol Psychiatry 2013
Zorumski CF, Nagele P, Me... Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... Front Psychiatry 2015
Pálenícek T, Lhotková E, ... Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmaco... Prog Neuropsychophar... 2016
Kang H, Park P, Bortolott... Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... Neuropharmacology 2017
Ingram R, Kang H, Lightma... Some distorted thoughts about ketamine as a psychedelic and a novel hy... Neuropharmacology 2018